JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266394

Human ATP5G2 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ATP5MC2 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human ATP5G2 knockout HEK-293T cell line (AB266394)
  • Sanger seq

Unknown

Sanger Sequencing - Human ATP5G2 knockout HEK-293T cell line (AB266394)

Homozygous : 1 bp insertion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266394-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266394-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266394 Human ATP5G2 knockout HEK-293T cell line", "number":"AB266394-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266394-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266394 Human ATP5G2 knockout HEK-293T cell line", "number":"AB266394-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266394-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266394-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266394 Human ATP5G2 knockout HEK-293T cell line", "number":"AB266394-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266394-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266394 Human ATP5G2 knockout HEK-293T cell line", "number":"AB266394-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ATP5MC2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ATP5G2 also known as ATP synthase subunit c mitochondrial 2 plays a mechanical role in the production of ATP. This protein functions as a component of the Fo subunit of ATP synthase which operates in the mitochondrial membrane. ATP5G2 has a mass of approximately 8.2 kDa and appears in tissues with high energy demand like muscle and nerve cells. The protein's primary role is to facilitate proton translocation across the mitochondrial membrane important for ATP synthesis.
Biological function summary

ATP5G2 contributes to the generation of cellular energy by being part of the ATP synthase complex also called Complex V of the mitochondrial electron transport chain. This complex performs oxidative phosphorylation converting ADP and inorganic phosphate into ATP which fuels various cellular processes. The subunit's function within the complex directly impacts cellular energy yields and efficiency. Its interaction with other ATP synthase subunits is vital for maintaining the function of the entire complex.

Pathways

ATP5G2 integrates into the oxidative phosphorylation pathway which is central to energy metabolism. This pathway is important for the conversion of nutrients into usable energy. ATP5G2 works closely with the NADH dehydrogenase complex (Complex I) to enable effective electron transport and subsequent ATP generation. The intricate coordination between these complexes is necessary for the maintenance of the mitochondrial membrane potential and overall cellular energetics.

Mutations or dysfunction in ATP5G2 can link to mitochondrial disorders such as Leigh syndrome which involves neurodegeneration and energy deficits. The protein's malfunction can disrupt ATP synthesis affecting the energy balance in cells particularly those requiring high ATP levels. Additionally ATP5G2 might contribute to metabolic disorders like diabetes where insulin secretion and action depend on proper energy metabolism. The role of ATP5G2 alongside other ATP synthase subunits highlights its importance in maintaining mitochondrial and cellular function.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com